1 Hensley L E, Young H A, Jahrling P B, et al. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett, 2002, 80: 169-179
[2]
2 Bray M, Geisbert T W. Ebola virus: The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol, 2005, 37: 1560-1566
[3]
3 Takada A L, Kawaoka Y. The pathogenesis of Ebola hemorrhagic fever. Trends Microbiol, 2001, 9: 506-511
[4]
4 Wauquier N, Becquart P, Padilla C, et al. Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis, 2010, 4: 10
[5]
5 Leroy E M, Baize S, Debre P, et al. Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol, 2001, 124, 453-460
[6]
6 Feldmann H, Geisbert T W. Ebola haemorrhagic fever. Lancet, 2011, 377: 849-862
[7]
7 Sharifi-Mood B, Alavi-Naini R, Metanat M, et al. Efficacy of high-dose methylprednisolone in patients with Crimean-Congo haemorrhagic fever and severe thrombocytopenia.Trop Doct, 2013, 43: 49-53
[8]
8 Rajapakse S. Corticosteroids in the treatment of dengue illness.Trans R Soc Trop Med Hyg, 2009, 103: 122-126
[9]
9 Shashidhara K C, Murthy K A S, Gowdappa H B, et al. Effect of high dose of steroid on plateletcount in acute stage of Dengue fever with thrombocytopenia. J Clin Diagn Res, 2013, 7: 1397-1400
[10]
10 Confalonieri M, D''Agaro P, Campello C. Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection. Intensive Care Med, 2010, 36: 1780-1781
